Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AGL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGLAgilon Health$2.21+4.0%$2.29$1.50▼$7.62$912.76M0.164.71 million shs879,105 shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGLAgilon Health0.00%-4.48%+0.71%-48.55%-69.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGLAgilon Health2.7613 of 5 stars4.12.00.00.03.20.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGLAgilon Health 2.17Hold$4.71113.80% UpsideCurrent Analyst Ratings BreakdownLatest ABDX, AGL, YGEN, and GDR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/9/2025AGLAgilon HealthEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetIn-Line ➝ In-Line$5.00 ➝ $3.005/13/2025AGLAgilon HealthWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$6.00 ➝ $5.005/8/2025AGLAgilon HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetUnderweight ➝ Underweight$2.00 ➝ $3.005/8/2025AGLAgilon HealthThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$2.50 ➝ $5.004/28/2025AGLAgilon HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform4/25/2025AGLAgilon HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$3.25 ➝ $5.00(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGLAgilon Health$6.06B0.15N/AN/A$1.14 per share1.93Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGLAgilon Health-$260.15M-$0.59N/AN/AN/A-4.04%-45.47%-12.76%8/5/2025 (Estimated)Latest ABDX, AGL, YGEN, and GDR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025AGLAgilon Health-$0.11N/AN/AN/A$1.47 billionN/A5/6/2025Q1 2025AGLAgilon Health-$0.01$0.03+$0.04$0.03$1.50 billion$1.53 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGLAgilon HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAGLAgilon HealthN/A1.201.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGLAgilon HealthN/AInsider OwnershipCompanyInsider OwnershipAGLAgilon Health3.57%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGLAgilon Health1,076413.95 million399.17 millionNot OptionableABDX, AGL, YGEN, and GDR HeadlinesRecent News About These CompaniesBrokerages Set Agilon Health, Inc. (NYSE:AGL) Price Target at $4.71July 16, 2025 | americanbankingnews.comCenterBook Partners LP Invests $8.32 Million in Agilon Health, Inc. (NYSE:AGL)July 15, 2025 | marketbeat.comAgilon Health, Inc. (NYSE:AGL) Receives Consensus Recommendation of "Hold" from AnalystsJuly 13, 2025 | marketbeat.comAgilon Health (NYSE:AGL) Shares Down 5.2% on Analyst DowngradeJuly 11, 2025 | americanbankingnews.comAgilon Health (NYSE:AGL) Stock Price Down 5.2% on Analyst DowngradeJuly 9, 2025 | marketbeat.comAgilon Health (NYSE:AGL) Price Target Cut to $3.00 by Analysts at Evercore ISIJuly 9, 2025 | marketbeat.comAgilon Health (NYSE:AGL) Shares Down 4.4% - Here's What HappenedJuly 2, 2025 | marketbeat.comagilon health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJune 27, 2025 | finance.yahoo.comAgilon Health, Inc. (NYSE:AGL) Shares Purchased by SG Americas Securities LLCJune 22, 2025 | marketbeat.comNew Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care ...June 9, 2025 | gurufocus.comNew Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare PatientsJune 9, 2025 | businesswire.comINVESTOR NOTICE: Kaskela Law LLC Announces Investigation of Agilon Health, Inc. and Encourages Long-Term Agilon Investors to Contact the Firm - AGLJune 9, 2025 | accessnewswire.comAAgilon Health’s SWOT analysis: stock faces headwinds amid profitability pushMay 28, 2025 | uk.investing.comagilon health to Participate in Bernstein's 41st Annual Strategic Decisions ConferenceMay 19, 2025 | gurufocus.comagilon health to Participate in Bernstein's 41st Annual Strategic Decisions ConferenceMay 19, 2025 | businesswire.com2 Healthcare Stocks with Promising Prospects and 1 to Think Twice AboutMay 12, 2025 | finance.yahoo.com7AGL : Assessing Agilon Health: Insights From 8 Financial AnalystsMay 8, 2025 | benzinga.comWhy agilon health (AGL) Stock Is NosedivingMay 7, 2025 | finance.yahoo.comagilon health, inc. (AGL) Q1 2025 Earnings Call TranscriptMay 6, 2025 | seekingalpha.comAgilon Health (AGL) Reports Break-Even Earnings for Q1May 6, 2025 | zacks.comagilon health (NYSE:AGL) Beats Q1 Sales TargetsMay 6, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeABDX, AGL, YGEN, and GDR Company DescriptionsAgilon Health NYSE:AGL$2.20 +0.09 (+4.01%) As of 12:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Q2 Could Be the Catalyst PayPal Investors Have Been Waiting For Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
